LONDON, May 21 (Reuters) - GlaxoSmithKline Plc , the world's second-largest drugs company by turnover, said sales of its asthma drug Advair would top 4 billion pounds ($7.9 billion) this year. "We are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results